ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country

Abstract

A majority of our ALK positive NSCLC patients were exposed to Crizotinib through the help of various support mechanisms and these patients had similar outcomes to that reported from previously published literature.